Flow Traders U.S.’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-80,549
Closed -$2.06M 1131
2025
Q4
$2.06M Buy
80,549
+47,660
+145% +$1.22M 0.07% 189
2025
Q3
$843K Sell
32,889
-30,076
-48% -$763K 0.03% 466
2025
Q2
$1.59M Buy
62,965
+29,756
+90% +$738K 0.06% 300
2025
Q1
$830K Sell
33,209
-34,860
-51% -$862K 0.04% 443
2024
Q4
$1.67M Buy
68,069
+31,835
+88% +$797K 0.07% 256
2024
Q3
$932K Buy
36,234
+24,924
+220% +$629K 0.05% 394
2024
Q2
$278K Sell
11,310
-1,000
-8% -$24.4K 0.01% 688
2024
Q1
$305K Buy
+12,310
New +$305K 0.02% 574

Other funds holding IBDX

Flow Traders U.S.'s IBDX Position: Q1 2026 in Review

Flow Traders U.S. sold out of iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q1 2026, closing a stake of 80,549 shares — an estimated $2.06M sold.

Flow Traders U.S. first reported a position in IBDX in Q1 2024 and held it in 8 quarters. The position peaked at $2.06M in Q4 2025. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

  • Flow Traders U.S. reported no remaining iShares iBonds Dec 2032 Term Corporate ETF position as of Q1 2026 after selling out during the quarter.
  • Flow Traders U.S. sold 80,549 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2026, an estimated $2.06M.
  • Flow Traders U.S. first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2024 and held it in 8 quarters.
  • Flow Traders U.S.'s iShares iBonds Dec 2032 Term Corporate ETF position peaked at $2.06M in Q4 2025.
  • 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.